Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Attention deficit disorder, stimulant use, and childhood body mass index trajectory.

Schwartz BS, Bailey-Davis L, Bandeen-Roche K, Pollak J, Hirsch AG, Nau C, Liu AY, Glass TA.

Pediatrics. 2014 Apr;133(4):668-76. doi: 10.1542/peds.2013-3427.

2.
3.

ADHD, stimulant treatment, and growth: a longitudinal study.

Harstad EB, Weaver AL, Katusic SK, Colligan RC, Kumar S, Chan E, Voigt RG, Barbaresi WJ.

Pediatrics. 2014 Oct;134(4):e935-44. doi: 10.1542/peds.2014-0428.

4.

Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.

Schertz M, Adesman AR, Alfieri NE, Bienkowski RS.

Pediatrics. 1996 Oct;98(4 Pt 1):763-9.

PMID:
8885958
5.

Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.

Palli SR, Kamble PS, Chen H, Aparasu RR.

J Child Adolesc Psychopharmacol. 2012 Apr;22(2):139-48. doi: 10.1089/cap.2011.0028.

PMID:
22364400
6.

Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Molina BS, Hinshaw SP, Eugene Arnold L, Swanson JM, Pelham WE, Hechtman L, Hoza B, Epstein JN, Wigal T, Abikoff HB, Greenhill LL, Jensen PS, Wells KC, Vitiello B, Gibbons RD, Howard A, Houck PR, Hur K, Lu B, Marcus S; MTA Cooperative Group..

J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250-63. doi: 10.1016/j.jaac.2012.12.014.

7.
8.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

9.

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.

J Dev Behav Pediatr. 2006 Feb;27(1):1-10.

PMID:
16511362
10.

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.

J Dev Behav Pediatr. 2014 Sep;35(7):448-57. doi: 10.1097/DBP.0000000000000099.

PMID:
25180895
11.

Association between binge eating and attention-deficit/hyperactivity disorder in two pediatric community mental health clinics.

Reinblatt SP, Leoutsakos JM, Mahone EM, Forrester S, Wilcox HC, Riddle MA.

Int J Eat Disord. 2015 Jul;48(5):505-11. doi: 10.1002/eat.22342.

12.

ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.

Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH.

Addict Behav. 2014 Jan;39(1):325-8. doi: 10.1016/j.addbeh.2013.09.002.

PMID:
24090624
13.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
14.

Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.

Mannuzza S, Klein RG, Truong NL, Moulton JL 3rd, Roizen ER, Howell KH, Castellanos FX.

Am J Psychiatry. 2008 May;165(5):604-9. doi: 10.1176/appi.ajp.2008.07091465.

16.

Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.

Leibson CL, Barbaresi WJ, Ransom J, Colligan RC, Kemner J, Weaver AL, Katusic SK.

Ambul Pediatr. 2006 Jan-Feb;6(1):45-53.

PMID:
16443183
17.

Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?

Rohatgi RK, Bos JM, Ackerman MJ.

Heart Rhythm. 2015 Aug;12(8):1807-12. doi: 10.1016/j.hrthm.2015.04.043.

18.

Thinner Medial Temporal Cortex in Adolescents With Attention-Deficit/Hyperactivity Disorder and the Effects of Stimulants.

Schweren LJ, Hartman CA, Heslenfeld DJ, van der Meer D, Franke B, Oosterlaan J, Buitelaar JK, Faraone SV, Hoekstra PJ.

J Am Acad Child Adolesc Psychiatry. 2015 Aug;54(8):660-7. doi: 10.1016/j.jaac.2015.05.014.

PMID:
26210335
19.

Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder.

Poulton AS, Melzer E, Tait PR, Garnett SP, Cowell CT, Baur LA, Clarke S.

Med J Aust. 2013 Jan 21;198(1):29-32.

PMID:
23330767
20.

ADHD medication use, adherence, persistence and cost among Texas Medicaid children.

Barner JC, Khoza S, Oladapo A.

Curr Med Res Opin. 2011;27 Suppl 2:13-22. doi: 10.1185/03007995.2011.603303.

PMID:
21973228
Items per page

Supplemental Content

Support Center